Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Part of paid clinical trials in Tucson, Arizona.

Sponsor
American College of Radiology Imaging Network
Study ID
NCT00023868
Phase
PHASE3
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

  • FOLFIRI regimen — DRUG
  • cisplatin — DRUG
  • doxorubicin hydrochloride — DRUG
  • fluorouracil — DRUG
  • irinotecan hydrochloride — DRUG
  • leucovorin calcium — DRUG
  • mitomycin C — DRUG

Study Details

RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. It is not yet known if chemoembolization is more effective than standard chemotherapy in treating metastatic cancer. PURPOSE: This phase I trial and randomized phase III trial is studying the effectiveness of chemoembolization in treating patients who have colorectal cancer metastatic to the liver.

Key Dates

Start date
Nov 1, 2001
Status verified
Nov 2020
Primary completion
Sep 25, 2002
Completion
Sep 25, 2002

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Locations (9)

Find similar trials in Tucson, AZ

By condition

Related Studies